SCHEMBL20420132

SCHEMBL20420132

CNc1ncnc2nc(C)[nH]c12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKT2 P31751 1/20 0.42
▸ PDPK1 O15530 1/20 0.42
▸ YTHDC1 Q96MU7 2/20 0.41
▸ YTHDF2 Q9Y5A9 2/20 0.41
▸ GSK3B P49841 1/20 0.40
▸ NUDT1 P36639 2/20 0.39
▸ XDH P47989 1/20 0.39
▸ KIT P10721 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ JAK1 P23458 1/20 0.38
▸ TYK2 P29597 1/20 0.38
▸ JAK3 P52333 1/20 0.38
▸ CSF1R P07333 2/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ TP53 P04637 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HBB P68871 1/20 0.35
▸ NCOA3 Q9Y6Q9 1/20 0.35
▸ ADORA3 P0DMS8 2/20 0.34
▸ ADORA2A P29274 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6515018 0.83 AKT2 (0.44) AKT2PDPK1GSK3BNUDT1KIT
SCHEMBL355788 0.81 GSK3B (0.41) PDPK1YTHDC1YTHDF2GSK3BNUDT1
SCHEMBL29923950 0.81 GSK3B (0.41) PDPK1YTHDC1YTHDF2GSK3BNUDT1
SCHEMBL16513126 0.78 BRAF (0.45) AKT2GSK3BKITTP53
SCHEMBL20420131 0.77 YTHDC1 (0.49) AKT2PDPK1YTHDC1YTHDF2CSF1R
SCHEMBL30534246 0.75 AKT2 (0.46) AKT2PDPK1NUDT1KITJAK2
SCHEMBL26926539 0.74 NUDT1 (0.37) NUDT1XDHADORA3ADORA2AADORA1
SCHEMBL8009111 0.73 CSF1R (0.71) CSF1RALDH1A1CYP2C19CYP1A2CYP3A4
Adenine SCHEMBL11149448 0.73 PI4KA (0.52) PDPK1NUDT1XDHALDH1A1TP53
SCHEMBL1059581 0.72 NUDT1 (0.68) AKT2NUDT1XDHALDH1A1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018134148-A1 SUBSTITUTED DIHYDROIMIDAZOPYRIDINEDIONES AS MKNK1 AND MKNK2 INHIBITORS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-07-26 — — WO disclosed
Send feedback